Status:
COMPLETED
MEMENTO-VAScular COmponents of Dementia
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Ministry for Health and Solidarity, France
Conditions:
Alzheimer's Disease (AD)
Alzheimer's Disease (AD) Related Disorders
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
A Multicenter national longitudinal cohort study including at least 800 individuals recruited from French Research Memory Centers and followed up over 36 months and included in Memento.
Detailed Description
Alzheimer's disease (AD) is a neurodegenerative disorder thought to be caused by the accumulation of the peptide amyloid beta and the hyperphosphorylated tau protein in the brain. There are increasing...
Eligibility Criteria
Inclusion
- Participants to MEMENTO-Vascod should be included in MEMENTO.
- To have signed a specific MEMENTO-Vascod informed consent form, prior to any Vascod ancillary study related procedures
- To be aged 50 years old and above
- To have a Clinical Dementia Rating scale \<0.5 and to be not demented;
Exclusion
- Are under guardianship
- Live in skilled nursing facility
- Are Pregnant or breast feeding women
- Meet brain MRI exclusion criteria (Same criteria as in Memento main protocol)
Key Trial Info
Start Date :
November 4 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 29 2021
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT02264899
Start Date
November 4 2014
End Date
October 29 2021
Last Update
January 28 2022
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens
Amiens, France
2
CHU de Bordeaux - Pellegrin
Bordeaux, France, 33000
3
CHU de Dijon
Dijon, France
4
CHU de Lille
Lille, France